Summit Therapeutics PLC

Stock Chart, Company Information, and Scan Results

$25.69(as of Aug 12, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Summit Therapeutics PLC Company Information, Fundamentals, and Technical Indicators

Stock Price$25.69
Ticker SymbolSMMT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees159
CountyUSA
Market Cap$20,980.3M
EBIDTA-235.4M
10-Day Moving Average27.77
P/E Ratio-78.74
20-Day Moving Average27.56
Forward P/E Ratio0.00
50-Day Moving Average23.96
Earnings per Share-0.34
200-Day Moving Average21.63
Profit Margin-Infinity%
RSI46.43
Shares Outstanding742.7M
ATR1.83
52-Week High36.91
Volume6,492,693
52-Week Low10.98
Most Recent Support Level27.10
Book Value344.3M
Most Recent Resistance Level29.36
P/B Ratio55.06
Upper Keltner31.68
P/S RatioInfinity
Lower Keltner23.43
Debt-to-Equity Ratio31.68
Next Earnings Date10/28/2025
Cash Surplus176.6M
Next Ex-Dividend DateUnknown

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.

Summit Therapeutics PLC In Our Stock Scanner

As of Aug 13, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.